LIMINATUS PHARMA INC. CL A
LIMINATUS PHARMA INC. CL A is a security (CUSIP 53271X108) tracked across SEC portfolio filings. 12 institutional managers reported $220K on Form 13F as of 2026-03-31; 1 registered fund positions totaling $9K via N-PORT as of 2026-03-31.
Summary
- Issuer: LIMINATUS PHARMA INC.
- Class: CL A
- CUSIP: 53271X108
- Asset category: EC
- 13F holders: 12
- 13F value: $220K
- 13F period: 2026-03-31
- N-PORT fund positions: 1
- N-PORT value: $9K
- N-PORT report: 2026-03-31
Top institutional holders (Form 13F)
| Manager | Location | Value | Shares |
|---|
| CITADEL ADVISORS LLC | MIAMI, FL | $116K | 677,518 |
| VANGUARD GROUP INC | Valley Forge, PA | $45K | 73,424 |
| GEODE CAPITAL MANAGEMENT, LLC | BOSTON, MA | $20K | 117,783 |
| JANE STREET GROUP, LLC | NEW YORK, NY | $12K | 71,318 |
| UBS Group AG | Zurich, V8 | $9K | 54,578 |
| Vanguard Personalized Indexing Management, LLC | OAKLAND, CA | $6K | 34,706 |
| TWO SIGMA SECURITIES, LLC | New York, NY | $4K | 22,039 |
| STATE STREET CORP | BOSTON, MA | $3K | 19,000 |
| BlackRock, Inc. | New York, NY | $2K | 13,254 |
| Tower Research Capital LLC (TRC) | NEW YORK, NY | $1K | 7,567 |
| Cygnus Capital Advisors, LLC | ATLANTA, GA | $60 | 350,000 |
| Virtu Financial LLC | New York, NY | $5 | 27,468 |
Top fund holders (N-PORT)
More